UK Anti-Doping v Adam Machaj

To optimise for archiving, the original image and related documents associated with this article have been removed.

A decision in the case of UK Anti-Doping (UKAD) v Adam Machaj has been published by the National Anti-Doping Panel (NADP).

On 02 December2019 Mr Adam Machaj, formerly a professional heavyweight boxer licensed by the British Boxing Board of Control, was charged with violating ADR 2.2 by the Use of three Prohibited Substances, Clomifene, Anastrozole, and Testosterone without having a Therapeutic Use of Exemption. Mr Machaj, subsequently admitted the Use of the substances and therefore committed Anti-Doping Rules Violations under ADR 2.2.

The NADP Tribunal, consisting of Robert Englehart QC, Lorraine Johnson and Dr Terry Crystal, had to consider the appropriate sanction and the length of the applicable period of Ineligibility. They imposed a period of four years.

A copy of the full decision can be accessed via the related links tab on the right-hand side.

The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping who is responsible for investigating, charging and prosecuting cases before the NADP.

You may also like

View All

ITIA v Aleksei Mokrov

A decision in the case of the International Tennis Integrity Agency against Mr Aleksei Mokrov has been issued by the Independent Panel

Read More

Former world number 2 tennis player Jabeur facing mental health battle due to demanding schedule

Former world number 2 tennis player Ons Jabeur has vocalised her mental health struggles due to a demanding schedule

Read More

FIDE to provide childcare support for elite players

As part of its “ChessMom” initiative, the International Chess Federation will provide childcare support for mothers competing in elite chess, returning in 2026 for the 46th Chess Olympiad in Uzbekistan

Read More